Shire's $32.5 billion acquisition of Baxalta will be announced as early as Monday.
Pfizer Inc. and Allergan Plc may announce an agreement as early as Monday to combine into a single new firm.
The combined firm would have more than 1,200 hospitals and about 20,000 doctors.
Sprout’s drug Addyi won approval from the FDA on Tuesday to treat a lack of sexual desire in women.
IPC specializes in providing medical staff for patients who are hospitalized or need additional follow-up care.
St. Jude is aiming to expand its portfolio of devices for the treatment of heart failure.
Bayer is shedding peripheral units as he focuses on more lucrative life-sciences operations.
The $1.2bn acquisition will boost Cardinal Health's generic drug distribution.
Opko will gain access to genetic data and sequencing technologies to aid medical discovery.
Most pharmacy benefit managers and pharmacy chain operators are consolidating.
Copyright © 2016. All rights reserved.